{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:41:42Z","timestamp":1787697702952,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.sapharm.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T03:11:43Z","timestamp":1618801903000},"page":"1893-1906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The management of asthma in adult patients in the community pharmacy setting: Literature review"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6332-8239","authenticated-orcid":false,"given":"Aseel","family":"Mahmoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-5550","authenticated-orcid":false,"given":"Charles","family":"Morecroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2021.04.001_bib1","article-title":"Why asthma still kills: the national review of asthma deaths (NRAD)confidential enquiry report","author":"Royal College of Physicians","year":"2015","journal-title":"RCP (Rev Cuba Pediatr)"},{"key":"10.1016\/j.sapharm.2021.04.001_bib2","series-title":"Asthma Fact Sheet. WHO","year":"2017"},{"key":"10.1016\/j.sapharm.2021.04.001_bib3","unstructured":"Asthma UK's press office. Asthma Facts and Statistics. www.asthmauk.org. https:\/\/www.asthma.org.uk\/about\/media\/facts-and-statistics\/. Accessed 20.8.2017."},{"key":"10.1016\/j.sapharm.2021.04.001_bib4","series-title":"Quality Standard (QS25)","author":"Asthma","year":"2013"},{"key":"10.1016\/j.sapharm.2021.04.001_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2466-9-24","article-title":"Economic burden of asthma: a systematic review","volume":"9","author":"Bahadori","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib7","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/npjpcrm.2015.4","article-title":"Why aren't we doing better in asthma: time for personalised medicine?","volume":"25","author":"Thomas","year":"2015","journal-title":"NPJ Primary Care Respirat Med"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib8","first-page":"228","article-title":"The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review","volume":"11","author":"Fathima","year":"2013","journal-title":"Pharm Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib9","unstructured":"GINA. Global intiative for asthma. Accessed 02\/03\/2021."},{"key":"10.1016\/j.sapharm.2021.04.001_bib10","series-title":"British Guideline on the Management of Asthma; A National Clinical Guideline","volume":"vol. 2020","year":"2019"},{"key":"10.1016\/j.sapharm.2021.04.001_bib11","series-title":"Asthma: Diagnosis,monitoring and Chronic Asthma Management NICE","year":"2017"},{"key":"10.1016\/j.sapharm.2021.04.001_bib12","author":"Asthma"},{"key":"10.1016\/j.sapharm.2021.04.001_bib14","series-title":"A Quick Guide to the Routine Management of Asthma in Primary Care","author":"UK PCRS","year":"2008"},{"key":"10.1016\/j.sapharm.2021.04.001_bib15","series-title":"Community Pharmacy Clinical Services Review","author":"Murray","year":"2016"},{"issue":"2","key":"10.1016\/j.sapharm.2021.04.001_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11096-016-0418-y","article-title":"Self-care of long-term conditions: patients' perspectives and their (limited) use of community pharmacies","volume":"39","author":"Ogunbayo","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"suppl 2","key":"10.1016\/j.sapharm.2021.04.001_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/thoraxjnl-2012-202678.370","article-title":"Reasons proffered for non-attendance at a difficult asthma clinic","volume":"67","author":"Mault","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.sapharm.2021.04.001_bib18","series-title":"The King's Fund. Ideas that Change Health Care Web Site","article-title":"The King's Fund: delivering better services for people with long term conditions: building the house of care","author":"Angela","year":"2013"},{"key":"10.1016\/j.sapharm.2021.04.001_bib19","series-title":"A Rapid Review of Evidence Regarding Clinical Services Commissioned from Community Pharmacies","author":"Wright","year":"2016"},{"key":"10.1016\/j.sapharm.2021.04.001_bib20","unstructured":"Pharmaceutical Services Negotiating Committee. About Community Pharmacy. www.psnc.org.uk. https:\/\/psnc.org.uk\/psncs-work\/about-community-pharmacy\/. Accessed."},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jep.12339","article-title":"Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT","volume":"21","author":"Rotta","year":"2015","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib22","unstructured":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Website. PRISMA Chicklist,. http:\/\/www.prisma-statement.org\/. Accessed 12.09.2020."},{"issue":"7-8","key":"10.1016\/j.sapharm.2021.04.001_bib23","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1345\/aph.1S006","article-title":"A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project","volume":"47","author":"Correr","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jep.12339","article-title":"Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT","volume":"21","author":"Rotta","year":"2015","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2021.04.001_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.japh.2017.12.009","article-title":"Characterization of pharmacists' interventions in asthma management: a systematic review","volume":"58","author":"Crespo-Gonzalez","year":"2018","journal-title":"J Am Pharmaceut Assoc"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1183\/13993003.01497-2015","article-title":"Pharmacists' interventions on clinical asthma outcomes: a systematic review","volume":"47","author":"Garcia-Cardenas","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sapharm.2021.04.001_bib27","unstructured":"Pharmaceutical Services Negotiating Committee. Services Database: Emergency Supply Service. www.psnc.org.uk. https:\/\/psnc.org.uk\/?our-services=urgent-repeat-medicines-service-via-pgd. Accessed 27.07.2018."},{"key":"10.1016\/j.sapharm.2021.04.001_bib28","series-title":"DEPICT 2 Manual","year":"2015"},{"key":"10.1016\/j.sapharm.2021.04.001_bib29","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses","author":"Wells","year":"2015"},{"issue":"6","key":"10.1016\/j.sapharm.2021.04.001_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.sapharm.2017.07.007","article-title":"Impact of community pharmacists' interventions on asthma self-management care","volume":"14","author":"Kovacevic","year":"2017","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2021.04.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-017-2245-9","article-title":"A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients","volume":"17","author":"Manfrin","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2021.04.001_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.rmed.2016.10.006","article-title":"Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease","volume":"120","author":"Apikoglu-Rabus","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.sapharm.2021.04.001_bib33","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/npjpcrm.2016.82","article-title":"Opportunities to develop the professional role of community pharmacists in the care of patients with asthma: a cross-sectional study","volume":"26","author":"Watkins","year":"2016","journal-title":"NPJ Prim Care Respir Med"},{"issue":"3","key":"10.1016\/j.sapharm.2021.04.001_bib34","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/02770903.2012.754463","article-title":"Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial","volume":"50","author":"Armour","year":"2013","journal-title":"J Asthma"},{"issue":"6","key":"10.1016\/j.sapharm.2021.04.001_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/thx.2006.064709","article-title":"Pharmacy asthma care program (PACP) improves outcomes for patients in the community [comparative study; multicenter study; randomized controlled trial; research support, non-U.S. Gov't]","volume":"62","author":"Armour","year":"2007","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.sapharm.2021.04.001_bib36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/jcpt.12017","article-title":"Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management [Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't]","volume":"38","author":"Bereznicki","year":"2013","journal-title":"J Clin Pharm Therapeut"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5694\/j.1326-5377.2008.tb01889.x","article-title":"Data-mining of medication records to improve asthma management [multicenter study; randomized controlled trial; research support, non-U.S. Gov't]","volume":"189","author":"Bereznicki","year":"2008","journal-title":"Med J Aust"},{"issue":"9","key":"10.1016\/j.sapharm.2021.04.001_bib38","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.rmed.2013.05.014","article-title":"Effect of a pharmacist intervention on asthma control. A cluster randomised trial [multicenter study; randomized controlled trial; research support, non-U.S. Gov't]","volume":"107","author":"Garc\u00eda-C\u00e1rdenas","year":"2013","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.sapharm.2021.04.001_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/02770903.2011.580032","article-title":"Inhaler technique maintenance: gaining an understanding from the patient's perspective","volume":"48","author":"Ovchinikova","year":"2011","journal-title":"J Asthma"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib40","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1183\/09031936.00112007","article-title":"Effectiveness of pharmacist intervention for asthma control improvement [Randomized Controlled Trial]","volume":"31","author":"Mehuys","year":"2008","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.sapharm.2021.04.001_bib41","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.socscimed.2006.11.006","article-title":"Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting","volume":"64","author":"Smith","year":"2007","journal-title":"Soc Sci Med"},{"issue":"10","key":"10.1016\/j.sapharm.2021.04.001_bib42","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/thorax.58.10.851","article-title":"Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial [Clinical Trial; Randomized Controlled Trial]","volume":"58","author":"Barbanel","year":"2003","journal-title":"Thorax"},{"issue":"13","key":"10.1016\/j.sapharm.2021.04.001_bib43","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1001\/jama.288.13.1594","article-title":"Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial","volume":"288","author":"Weinberger","year":"2002","journal-title":"J Am Med Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2021.04.001_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/00912700122010438","article-title":"Pharmaceutical care services for asthma patients: a controlled intervention study [clinical trial; controlled clinical trial; research support, non-U.S. Gov't]","volume":"41","author":"Schulz","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.sapharm.2021.04.001_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2017.05.019","article-title":"Testing evidence routine practice: using an implementation framework to embed a clinically proven asthma service in Australian community pharmacy","author":"Fuller","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"12","key":"10.1016\/j.sapharm.2021.04.001_bib46","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.rmed.2011.07.004","article-title":"Inhaler technique and asthma: feasability and acceptability of training by pharmacists","volume":"105","author":"Giraud","year":"2011","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.2042-7174.2002.tb00588.x","article-title":"Pharmacists solving problems in asthma management \u2014 experiences from a one-year intervention programme in Finland","volume":"10","author":"N\u00e4rhi","year":"2002","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib48","article-title":"Role of a community pharmacy service in care of bronchial asthma patients in Lithuania","volume":"2018","author":"Nastaravi\u010dius","year":"2018","journal-title":"Can Respir J J Can Thorac Soc"},{"key":"10.1016\/j.sapharm.2021.04.001_bib49","doi-asserted-by":"crossref","first-page":"106199","DOI":"10.1016\/j.rmed.2020.106199","article-title":"Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma","volume":"174","author":"Paoletti","year":"2020","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.sapharm.2021.04.001_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jval.2011.12.010","article-title":"Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report","volume":"15","author":"Berger","year":"2012","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.sapharm.2021.04.001_bib52","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/rmed.2001.1184","article-title":"Using a revised asthma morbidity index to identify varying patterns of morbidity in U.K. general practices","volume":"95","author":"Unwin","year":"2001","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0738-3991(85)90041-2","article-title":"At last, a definition","volume":"7","author":"Bartlett","year":"1985","journal-title":"Patient Educ Counsel"},{"key":"10.1016\/j.sapharm.2021.04.001_bib54","series-title":"PSNC Briefing 042\/19: Pharmacy Quality Scheme \u2013 Asthma Referrals","year":"2019"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-5908-5-67","article-title":"Systematic evaluation of implementation fidelity of complex interventions in health and social care","volume":"5","author":"Hasson","year":"2010","journal-title":"Implement Sci"},{"key":"10.1016\/j.sapharm.2021.04.001_bib56","doi-asserted-by":"crossref","first-page":"a1655","DOI":"10.1136\/bmj.a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"Br Med J"},{"key":"10.1016\/j.sapharm.2021.04.001_bib57","series-title":"The Future of Pharmacy in a Sustainable NHS: Key Principles for Transformation and Growth","author":"Pharmaceutical Society","year":"2020"},{"key":"10.1016\/j.sapharm.2021.04.001_bib58","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3389\/fphar.2018.01352","article-title":"The connected community pharmacy: benefits for healthcare and implications for health policy","volume":"9","author":"Goundrey-Smith","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/ijpp.12165","article-title":"An evaluation of a multi-site community pharmacy\u2013based chronic obstructive pulmonary disease support service","volume":"23","author":"Wright","year":"2015","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2021.04.001_bib60","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.sapharm.2018.03.062","article-title":"The pharmacy care plan service: evaluation and estimate of cost-effectiveness","volume":"15","author":"Twigg","year":"2019","journal-title":"Res Soc Adm Pharm : RSAP"},{"key":"10.1016\/j.sapharm.2021.04.001_bib61","first-page":"19","article-title":"Community pharmacy: an untapped patient data resource","volume":"5","author":"Wright","year":"2016","journal-title":"Integrated Pharm Res Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib62","article-title":"Telehealthcare for asthma","volume":"10","author":"McLean","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"10.1016\/j.sapharm.2021.04.001_bib63","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/ajhp\/56.14.1405","article-title":"Telemedicine and telepharmacy: current status and future implications","volume":"56","author":"Angaran","year":"1999","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2021.04.001_bib64","first-page":"1134","article-title":"Pharmacists providing care in the outpatient setting through telemedicine models: a narrative review","volume":"15","author":"Littauer","year":"2017","journal-title":"Pharm Pract"},{"key":"10.1016\/j.sapharm.2021.04.001_bib65","article-title":"Examining the implications of analytical and remote monitoring in pharmacy practice","author":"Melissa","year":"2017","journal-title":"Pharmaceut J"},{"issue":"3","key":"10.1016\/j.sapharm.2021.04.001_bib66","first-page":"302","article-title":"Novel educational training program for community pharmacists","volume":"64","author":"de Almeida Neto","year":"2000","journal-title":"Am J Pharmaceut Educ"},{"key":"10.1016\/j.sapharm.2021.04.001_bib67","unstructured":"PROSPERO. International Prospective Register of Systematic Reviews. https:\/\/www.crd.york.ac.uk\/PROSPERO\/. Accessed 15.09.2020."}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:25:06Z","timestamp":1761557106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741121001248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1551741121001248"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.04.001","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The management of asthma in adult patients in the community pharmacy setting: Literature review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}